Skip to main content
NCBI home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2001 May 3;15(3):131–137. doi: 10.1002/jcla.1016

Real‐time identification of Pseudomonas aeruginosa direct from clinical samples using a rapid extraction method and polymerase chain reaction (PCR)

Richard I Jaffe 1,✉, Janae D Lane 1, Christopher W Bates 1
PMCID: PMC6807775  PMID: 11344528

Abstract

Pseudomonas aeruginosa has emerged as one of the most problematic Gram‐negative nosocomial pathogens. Bacteremia caused by P. aeruginosa is clinically indistinguishable from other Gram‐negative infections although the mortality rate is higher. This microorganism is also inherently resistant to common antibiotics. Standard bacterial identification and susceptibility testing is normally a 48‐hour process and difficulty sometimes exists in rapidly and accurately identifying antimicrobial resistance. The Polymerase Chain Reaction (PCR) is a rapid and simple process for the amplification of target DNA sequences. However, many sample preparation methods are unsuitable for the clinical laboratory because they are not cost effective, take too long to perform, or do not provide a good template for PCR. Our goal was to provide same‐day results to facilitate rapid diagnosis. In this report, we have utilized our rapid DNA extraction method to generate bacterial DNA direct from clinical samples for PCR. The lower detection level for P. aeruginosa was estimated to be 10 CFU/ml. In addition, we wanted to compare the results of a new rapid‐cycle DNA thermocycler that uses continuous fluorescence monitoring with the results of standard thermocycling. We tested 40 clinical isolates of P. aeruginosa and 18 non‐P. aeruginosa isolates received in a blinded fashion. Coded data revealed that there was 100% correlation in both the rapid‐cycle DNA thermocycling and standard thermocycling when compared to standard clinical laboratory results. In addition, total results turn‐around time was less than 1 hour. Specific identification of P. aeruginosa was determined using intragenic primer sets for bacterial 16S rRNA and Pseudomonas outer‐membrane lipoprotein gene sequences. The total cost of our extraction method and PCR was $2.22 per sample. The accuracy and rapidness of this DNA‐extraction method, with its PCR‐based identification system, make it an ideal candidate for use in the clinical laboratory. J. Clin. Lab. Anal. 15:131–137, 2001. © 2001 Wiley‐Liss, Inc.

Keywords: polymerase chain reaction (PCR), bacteria, DNA extraction, real‐time fluorescence, clinical samples, rapid PCR, Pseudomonas

REFERENCES

  • 1. Pfaller MA, Barrett M, Koontz FP, et al. 1989. Clinical evaluation of a direct fluorescent monoclonal antibody test for detection of Pseudomonas aeruginosa in blood cultures. J Clin Microbiol 27:558–560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Miller PJ, Wenzel RP. 1984. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 156:471–477. [DOI] [PubMed] [Google Scholar]
  • 3. Richard P, Le Floch R, Chamoux C, Pannier M, Espaze E, Richet H. 1994. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 170:377–383. [DOI] [PubMed] [Google Scholar]
  • 4. Pittet D, Li N, Woolson RF, Wenzel RP. 1997. Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6‐year validated population‐based model. Clin Infect Dis 24:1068–1078. [DOI] [PubMed] [Google Scholar]
  • 5. Weinstein MP, Towns ML, Quatery SM, et al. 1997. The clinical significance of positive blood cultures in the 1990’s: a prospective comprehensive evaluation of the microbiology, epidemiology and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584–602. [DOI] [PubMed] [Google Scholar]
  • 6. De Vos D, Lim A Jr, Pirnay JP, et al. 1997. Direct identification of Pseudomonas aeruginosa in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL. J Clin Microbiol 35:1295–1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. da Silva Filho LV, Levi JE, Oda Bento CN, da Silva Ramos SR, Rozov T. 1999. PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients. J Med Microbiol 48:357–361. [DOI] [PubMed] [Google Scholar]
  • 8. Turenne CY, Witwicki E, Hoban DJ, Karlowsky JA, Kabani AM. 2000. Rapid identification of bacteria from positive blood cultures by fluorescence‐based PCR‐single‐strand confirmation polymorph analysis of the 16S rRNA gene. J Clin Microbiol 38:513–520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Speijer H, Savelkoul PH, Bonten MJ, Stobberingh EE, Tjhie JH. 1999. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37:3654–3661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. O’Callaghan EM, Tanner MS, Boulnois GL. 1994. Development of a PCR probe test for identifying Pseudomonas aeruginosa and Pseudomonas (Burkholderia) cepacia . J Clin Pathol 47:222–226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Ghozzi R, Morand P, Ferroni A, et al. 1999. Capillary electrophoresis‐single‐strand confirmation polymorphism analysis for rapid identification of Pseudomonas aeruginosa and other Gram‐negative non‐fermenting bacilli recovered from patients with cystic fibrosis. J Clin Microbiol 37:3374–3379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Khan AA, Cerniglia CE. 1994. Detection of Pseudomonas aeruginosa from clinical and environmental samples by amplification of exotoxin A gene using PCR. Appl Environ Microbiol 60:3739–3745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Jaffe RI, Lane JD, Albury SV, Niemeyer DM. 2000. Rapid extraction from and direct identification in clinical samples of methicillin‐resistant staphylococci using PCR. J Clin Microbiol 38:3407–3412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. 1997. Continuous fluorescence monitoring of rapid cycle DNA amplification. BioTechniques 22:130–138, . [DOI] [PubMed] [Google Scholar]
  • 15. Dion M, Menard C, Picard FJ, et al. Program and abstracts of the 99th Annual General National Meeting of American Society for Microbiologists (ASM), Chicago, IL; 1999. p 203.
  • 16. McIntosh I, Govan JRW, Brock DJH. 1992. Detection of Pseudomonas aeruginosa in sputum from cystic fibrosis patients by the polymerase chain reaction. Mol Cell Probes 6:299–304. [DOI] [PubMed] [Google Scholar]
  • 17. Niemeyer DM, Jaffe RI, Wiggins LB. 2000. Feasibility determination for use of Polymerase Chain Reaction (PCR) in the USAF Air Transportable Hospital (ATH) field environment: lessons learned. Mil Med 165:10–15. [PubMed] [Google Scholar]
  • 18. Niemeyer DM, Dempsey M, Hamilton W, et al. Initial assessment of rapid PCR testing in the field hospital lpar;abstr) 1560. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology. San Francisco, CA; 1999. p. 222.
  • 19. Relman DA, Schmidt TM, MacDermont RP, Falkow S. 1992. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 323:1573–1580. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES